Enterprise Value
86.23M
Cash
7.976M
Avg Qtr Burn
-6.692M
Short % of Float
7.14%
Insider Ownership
15.74%
Institutional Own.
14.41%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Approved Quarterly sales | ||
MYDCOMBI™ (trop+phen) (MicroStat) Details Eye disease | Approved Quarterly sales | |
MicroPine (Atropine) Details Eye disease | Phase 3 Data readout | |
MicroLine (Apersure™) Details Eye disease | Phase 3 Update |